In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Adverse reactions attributed to entire drug class 'Biologic'
Please login to view adverse reactions.
Bullous pemphigoid / pemphigoid
- (2022): Husein-ElAhmed H+, J Dermatolog Treat Jun, Online ahead of print (15 cases) [REVIEW] (Naranjo Adverse Drug Reaction Probability Scale)
Leukocytoclastic vasculitis (angiitis)
- (2022): da Silva Cendon Duran C+, Arch Rheumatol 37(2), 300-310 [REVIEW]
- (2020): Afach S+, Br J Dermatol May, Online ahead of print [REVIEW]
- (2020): Montolio Chiva L+, Reumatol Clin Mar, Epub ahead of print [REVIEW]
Vasculitis (angiitis) / cutaneous vasculitis (angiitis)
- (2016): Gutierrez-Gonzalez LA, Curr Rheumatol Rep 18(7), 39 [REVIEW]
Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)
- (2021): Jee A+, Int J Mol Sci 22(6), 2954 [REVIEW]
- (2016): Al-Mayouf SM+, Int J Rheum Dis 19(6), 60034%
Uveitis / anterior uveitis / posterior uveitis / panuveitis
- (2020): Klein A+, ACR Open Rheumatol 2(1), 376%
Adverse effects / adverse reactions
- (2023): Herndon TM+, PLoS One 18(10), e0292231 [REVIEW]
- (2020): Iannone LF+, PLoS One 15(11) (e-Collection)
- (2020): Roberti R+, Curr Med Res Opin Jun, Online ahead of print
- (2016): Al-Mayouf SM+, Int J Rheum Dis 19(6), 60035%
- (2020): Klein A+, ACR Open Rheumatol 2(1), 373%
